Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade Marina NatoliNair BonitoYumeng Mao Original Article Open access 21 March 2020 Pages: 1391 - 1401
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade Marina NatoliNair BonitoYumeng Mao Correction Open access 18 June 2020 Pages: 1403 - 1408
Knocking out matrix metalloproteinase 12 causes the accumulation of M2 macrophages in intestinal tumor microenvironment of mice Mingming YangXiaohan ZhangJiangchao Li Original Article 02 April 2020 Pages: 1409 - 1421
The glucocorticoids prednisone and dexamethasone differentially modulate T cell function in response to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade Isobel S. OkoyeLai XuShokrollah Elahi Original Article 03 April 2020 Pages: 1423 - 1436
Expression of the immune checkpoint VISTA in breast cancer Liju ZongShengwei MoYang Xiang Original Article 07 April 2020 Pages: 1437 - 1446
Correction to: Expression of the immune checkpoint VISTA in breast cancer Liju ZongShengwei MoYang Xiang Correction 18 June 2020 Pages: 1447 - 1447
Neuroendocrine tumours and their microenvironment Lotte D. de HossonTim J. TakkenkampAnnemiek M. E. Walenkamp Original Article Open access 08 April 2020 Pages: 1449 - 1459
Interleukin-33 pretreatment promotes metastatic growth of murine melanoma by reducing the cytotoxic capacity of CD8+ T cells and enhancing regulatory T cells Andra JevtovicJelena PanticGordana D. Radosavljevic Original Article 13 April 2020 Pages: 1461 - 1475
Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment Qiaofei LiuHuanwen WuYupei Zhao Original Article 13 April 2020 Pages: 1477 - 1492
Characterization of CD103+ CD8+ tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade Lu HanQuan-Li GaoYan-Feng Gao Original Article 13 April 2020 Pages: 1493 - 1504
PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade Marcel P. TrefnyMonika KaiserAlfred Zippelius Original Article 15 April 2020 Pages: 1505 - 1517
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer Kyle G. MitchellBehrang AminiTina Cascone Original Article 16 April 2020 Pages: 1519 - 1534
Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential Moritz BewarderGerhard HeldFrank Neumann Original Article Open access 16 April 2020 Pages: 1535 - 1548
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density? Triantafyllia KoletsaVassiliki KotoulaGeorge Fountzilas Original Article 18 April 2020 Pages: 1549 - 1564
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients Yu QiYu XiaJiejie Xu Original Article 18 April 2020 Pages: 1565 - 1576
Characterising the prognostic potential of HLA-DR during colorectal cancer development Margaret R. DunneJames J. PhelanJacintha O’Sullivan Original Article Open access 18 April 2020 Pages: 1577 - 1588
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma Alessandra ZeccaValeria BariliGabriele Missale Original Article 19 April 2020 Pages: 1589 - 1603
Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort Sabine SchmidLaetitia A. MautiMartin Früh Original Article 19 April 2020 Pages: 1605 - 1613
Epstein–Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact Timo CarpénStina SyrjänenJaana Hagström Original Article Open access 20 April 2020 Pages: 1615 - 1626
Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer Martin M. WatsonDordi LeaKjetil Søreide Original Article Open access 20 April 2020 Pages: 1627 - 1637
NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences Esra NizamSadi KöksoyNuray Erin Original Article 22 April 2020 Pages: 1639 - 1650
A phase I study of multi-HLA-binding peptides derived from heat shock protein 70/glypican-3 and a novel combination adjuvant of hLAG-3Ig and Poly-ICLC for patients with metastatic gastrointestinal cancers: YNP01 trial Masao NakajimaShoichi HazamaHiroaki Nagano Clinical Trial Report Open access 26 March 2020 Pages: 1651 - 1662
Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial Amir KhammariJean-Michel NguyenBrigitte Dréno Clinical Trial Report 18 April 2020 Pages: 1663 - 1672
